
|Articles|September 1, 2002
Varicella vaccine could be effective zoster prophylactic for older patients
Stanford, Calif. - Use of an inactivated varicella vaccine may prevent immunocompromised patients from developing varicella-zoster virus infection for up to a year, Ann Arvin, M.D., said. She and colleagues published a recent study in the New England Journal of Medicine showing up to 20 percent fewer patients who were varicella seropositive developed zoster a year after a hematopoietic cell transplant.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















